Cargando…
Late mortality in survivors of childhood cancer in Hungary
The Hungarian Pediatric Oncology Network provides centralized treatment and population-based registration for cases of childhood cancer since 1973. We collected and analized data on late mortality, secondary malignancies and cardiac diseases in survivors (> 5 years) of childhood cancer to evaluat...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329824/ https://www.ncbi.nlm.nih.gov/pubmed/32612167 http://dx.doi.org/10.1038/s41598-020-67444-1 |
_version_ | 1783552978335039488 |
---|---|
author | Jakab, Zsuzsanna Garami, Miklos Bartyik, Katalin Csoka, Monika Erdelyi, Daniel Janos Hauser, Peter Juhasz, Attila Kelemen, Agnes Krivan, Gergely Masat, Peter Müller, Judit Nagy, Csilla Peter, György Renyi, Imre Szegedi, Istvan Vojcek, Agnes Zombori, Marianna Bardi, Edit Kovacs, Gabor |
author_facet | Jakab, Zsuzsanna Garami, Miklos Bartyik, Katalin Csoka, Monika Erdelyi, Daniel Janos Hauser, Peter Juhasz, Attila Kelemen, Agnes Krivan, Gergely Masat, Peter Müller, Judit Nagy, Csilla Peter, György Renyi, Imre Szegedi, Istvan Vojcek, Agnes Zombori, Marianna Bardi, Edit Kovacs, Gabor |
author_sort | Jakab, Zsuzsanna |
collection | PubMed |
description | The Hungarian Pediatric Oncology Network provides centralized treatment and population-based registration for cases of childhood cancer since 1973. We collected and analized data on late mortality, secondary malignancies and cardiac diseases in survivors (> 5 years) of childhood cancer to evaluate long-term risks. We extracted all solid tumour cases (3,650 followed up for 5–39.3 years, diagnosis: 1973–2008) from the database of the Hungarian Childhood Cancer Registry and checked against the Population Registry. Among the 301 patients who died after 5 years (8.2%) the most common causes of death were progression of primary cancer (52.5%), secondary malignancies (16%) and cardiovascular diseases (8%). Late mortality rates (SMR, total: 35,006 pyrs) showed highly elevated risk of death (SMR: 10.7 95% CI 9–12.4) for the second 5 years of follow up and moderately elevated risk for 10-year survivors (SMR: 3.5 95% CI 3–4.1). Marked differences were detected in the pattern of causes of death between diagnostic groups of primary cancer; with highest risks beyond 10 years for CNS tumours, Hodgkin disease, osteosarcoma and advanced stage neuroblastoma. The longstanding mortality risk for 5-year survivors underlines the need for tailored long-term follow-up and monitoring of late consequences according to the context of different primary diseases of childhood cancer. |
format | Online Article Text |
id | pubmed-7329824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73298242020-07-06 Late mortality in survivors of childhood cancer in Hungary Jakab, Zsuzsanna Garami, Miklos Bartyik, Katalin Csoka, Monika Erdelyi, Daniel Janos Hauser, Peter Juhasz, Attila Kelemen, Agnes Krivan, Gergely Masat, Peter Müller, Judit Nagy, Csilla Peter, György Renyi, Imre Szegedi, Istvan Vojcek, Agnes Zombori, Marianna Bardi, Edit Kovacs, Gabor Sci Rep Article The Hungarian Pediatric Oncology Network provides centralized treatment and population-based registration for cases of childhood cancer since 1973. We collected and analized data on late mortality, secondary malignancies and cardiac diseases in survivors (> 5 years) of childhood cancer to evaluate long-term risks. We extracted all solid tumour cases (3,650 followed up for 5–39.3 years, diagnosis: 1973–2008) from the database of the Hungarian Childhood Cancer Registry and checked against the Population Registry. Among the 301 patients who died after 5 years (8.2%) the most common causes of death were progression of primary cancer (52.5%), secondary malignancies (16%) and cardiovascular diseases (8%). Late mortality rates (SMR, total: 35,006 pyrs) showed highly elevated risk of death (SMR: 10.7 95% CI 9–12.4) for the second 5 years of follow up and moderately elevated risk for 10-year survivors (SMR: 3.5 95% CI 3–4.1). Marked differences were detected in the pattern of causes of death between diagnostic groups of primary cancer; with highest risks beyond 10 years for CNS tumours, Hodgkin disease, osteosarcoma and advanced stage neuroblastoma. The longstanding mortality risk for 5-year survivors underlines the need for tailored long-term follow-up and monitoring of late consequences according to the context of different primary diseases of childhood cancer. Nature Publishing Group UK 2020-07-01 /pmc/articles/PMC7329824/ /pubmed/32612167 http://dx.doi.org/10.1038/s41598-020-67444-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Jakab, Zsuzsanna Garami, Miklos Bartyik, Katalin Csoka, Monika Erdelyi, Daniel Janos Hauser, Peter Juhasz, Attila Kelemen, Agnes Krivan, Gergely Masat, Peter Müller, Judit Nagy, Csilla Peter, György Renyi, Imre Szegedi, Istvan Vojcek, Agnes Zombori, Marianna Bardi, Edit Kovacs, Gabor Late mortality in survivors of childhood cancer in Hungary |
title | Late mortality in survivors of childhood cancer in Hungary |
title_full | Late mortality in survivors of childhood cancer in Hungary |
title_fullStr | Late mortality in survivors of childhood cancer in Hungary |
title_full_unstemmed | Late mortality in survivors of childhood cancer in Hungary |
title_short | Late mortality in survivors of childhood cancer in Hungary |
title_sort | late mortality in survivors of childhood cancer in hungary |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329824/ https://www.ncbi.nlm.nih.gov/pubmed/32612167 http://dx.doi.org/10.1038/s41598-020-67444-1 |
work_keys_str_mv | AT jakabzsuzsanna latemortalityinsurvivorsofchildhoodcancerinhungary AT garamimiklos latemortalityinsurvivorsofchildhoodcancerinhungary AT bartyikkatalin latemortalityinsurvivorsofchildhoodcancerinhungary AT csokamonika latemortalityinsurvivorsofchildhoodcancerinhungary AT erdelyidanieljanos latemortalityinsurvivorsofchildhoodcancerinhungary AT hauserpeter latemortalityinsurvivorsofchildhoodcancerinhungary AT juhaszattila latemortalityinsurvivorsofchildhoodcancerinhungary AT kelemenagnes latemortalityinsurvivorsofchildhoodcancerinhungary AT krivangergely latemortalityinsurvivorsofchildhoodcancerinhungary AT masatpeter latemortalityinsurvivorsofchildhoodcancerinhungary AT mullerjudit latemortalityinsurvivorsofchildhoodcancerinhungary AT nagycsilla latemortalityinsurvivorsofchildhoodcancerinhungary AT petergyorgy latemortalityinsurvivorsofchildhoodcancerinhungary AT renyiimre latemortalityinsurvivorsofchildhoodcancerinhungary AT szegediistvan latemortalityinsurvivorsofchildhoodcancerinhungary AT vojcekagnes latemortalityinsurvivorsofchildhoodcancerinhungary AT zomborimarianna latemortalityinsurvivorsofchildhoodcancerinhungary AT bardiedit latemortalityinsurvivorsofchildhoodcancerinhungary AT kovacsgabor latemortalityinsurvivorsofchildhoodcancerinhungary |